BRAF and familial pancreatic carcinoma: Thus, the binding of ALA to MrgD in pancreatic cancer cell lines induces an antiproliferative effect by inhibiting the BRAF–MKK–ERK and PI3K–AKT pathways and activating FoxO1 [24].